Imagen de Portada

Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats

Abstract Background The current work aimed to assess whether Gynostemma pentaphyllum (GP), a Chinese herbal medicine, structurally modifies the gut microbiota in rats during non-alcoholic fatty liver disease (NAFLD) treatment. Methods High-fat diet (HFD)-induced NAFLD rats were orally administered w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shu-Hua Shen (Autor), Ting-Yan Zhong (Autor), Cui Peng (Autor), Jie Fang (Autor), Bin Lv (Autor)
Formato:	Libro
Publicado:	BMC, 2020-02-01T00:00:00Z.
Materias:	article
Acceso en línea:	Connect to this object online.
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Anti-atherosclerotic effects of Camellia chrysantha and Gynostemma pentaphyllum extracts mixture
por: Hong Hanh Nguyen, et al.
Publicado: (2023)

Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials
por: Ning Dai, et al.
Publicado: (2022)

New natural protein tyrosine phosphatase 1B inhibitors from Gynostemma pentaphyllum
por: Xianting Wang, et al.
Publicado: (2024)

Network pharmacology analysis reveals neuroprotection of Gynostemma pentaphyllum (Thunb.) Makino in Alzheimer' disease
por: Jiahao Wang, et al.
Publicado: (2022)

Gynostemma pentaphyllum promotes skeletal muscle recovery via its inhibition of PXR-IL-6 expression
por: Houran Cao, et al.
Publicado: (2022)

Protective effect of heat-processed Gynostemma pentaphyllum on high fat diet-induced glucose metabolic disorders mice
por: Jin-Bo Xie, et al.
Publicado: (2023)

Protective effect of gypenoside LXXV from Gynostemma pentaphyllum against oxidative stress-induced retinal degeneration in vitro and in vivo
por: Do Yeon Kim, et al.
Publicado: (2021)

New dammarane-type triterpenoids from hydrolyzate of total Gynostemma pentaphyllum saponins with protein tyrosine phosphatase 1B inhibitory activity
por: Daopeng Tan, et al.
Publicado: (2023)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Xiangbing Shu, et al.
Publicado: (2021)

Non-alcoholic fatty liver and the gut microbiota
por: Stavros Bashiardes, et al.
Publicado: (2016)

Chemical Constituents, Antioxidant, and α-Glucosidase Inhibitory Activities of Different Fermented <i>Gynostemma Pentaphyllum</i> Leaves and Untargeted Metabolomic Measurement of the Metabolite Variation
por: Xuechun Zhang, et al.
Publicado: (2023)

Gynostemma Pentaphyllum ameliorates CCl4-induced liver injury via PDK1/Bcl-2 pathway with comprehensive analysis of network pharmacology and transcriptomics
por: Linlan Hu, et al.
Publicado: (2024)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Sa Yang, et al.
Publicado: (2022)

Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis
por: Bo Shen, et al.
Publicado: (2022)

Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
por: Li Wang, et al.
Publicado: (2022)

Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
por: Dongliang Chen, et al.
Publicado: (2024)

Exercise Preconditioning Ameliorates Cognitive Impairment in Mice with Ischemic Stroke by Alleviating Inflammation and Modulating Gut Microbiota
por: Heng Lv, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
por: Doaa El Amrousy, et al.
Publicado: (2024)

Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice
por: Rong Li, et al.
Publicado: (2022)

The modulation of gut microbiota by herbal medicine to alleviate diabetic kidney disease - A review
por: Jinxin Du, et al.
Publicado: (2022)

Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Qingling Chen, et al.
Publicado: (2023)

Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids
por: Benchi Cai, et al.
Publicado: (2023)

Wangshi Baochi Pills alleviate alcoholic liver disease by regulating the gut microbiota composition in a mouse model
por: Song Ye, et al.
Publicado: (2023)

Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
por: Na Wang, et al.
Publicado: (2022)

The Chinese herbal prescription Kang-Gong-Yan alleviates cervicitis by modulating metabolites and gut microbiota
por: Yanni Zhao, et al.
Publicado: (2024)

Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia
por: Hai-Jun Li, et al.
Publicado: (2023)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Masayoshi Ko, et al.
Publicado: (2021)

A Combination of Deep-Sea Water and Fucoidan Alleviates T2DM through Modulation of Gut Microbiota and Metabolic Pathways
por: Shan He, et al.
Publicado: (2023)

Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota
por: Haibo Hu, et al.
Publicado: (2023)

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
por: Zhang DY, et al.
Publicado: (2019)

Porphyran From Porphyra haitanensis Alleviates Obesity by Reducing Lipid Accumulation and Modulating gut Microbiota Homeostasis
por: Xueliang Wang, et al.
Publicado: (2022)

Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
por: Qiuyue Hu, et al.
Publicado: (2022)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Masayoshi Ko, et al.
Publicado: (2023)

Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
por: Hu Li, et al.
Publicado: (2021)

Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats
por: Yuan Zhou, et al.
Publicado: (2022)

Sijunzi decoction alleviates inflammation and intestinal epithelial barrier damage and modulates the gut microbiota in ulcerative colitis mice
por: Hailun Li, et al.
Publicado: (2024)

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines
por: Wuwen Feng, et al.
Publicado: (2018)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
por: Yuzhen Zhao, et al.
Publicado: (2019)

Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier
por: Feng T, et al.
Publicado: (2024)

Golden bile powder prevents drunkenness and alcohol-induced liver injury in mice via the gut microbiota and metabolic modulation
por: Yarong Wang, et al.
Publicado: (2024)